SPONSOR
UNC Lineberger Comprehensive Cancer Center
Total Trials
11
Recruiting
11
Phases
Phase 1, Phase 2
Conditions studied: Health BehaviorBreast CancerLymph Node MetastasisOvary NeoplasmOvarian CancerEpithelial Ovarian CancerRecurrentBreast NeoplasmsSolid Tumor MalignanciesMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Health Behavior, Breast Cancer, Lymph Node Metastasis, Ovary Neoplasm.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — UNC Lineberger Comprehensive Cancer Center
How many clinical trials has UNC Lineberger Comprehensive Cancer Center sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by UNC Lineberger Comprehensive Cancer Center, of which 11 are actively recruiting participants. These trials cover conditions including Health Behavior, Breast Cancer, Lymph Node Metastasis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does UNC Lineberger Comprehensive Cancer Center research focus on?
UNC Lineberger Comprehensive Cancer Center clinical trials span Health Behavior, Breast Cancer, Lymph Node Metastasis, Ovary Neoplasm, Ovarian Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a UNC Lineberger Comprehensive Cancer Center clinical trial?
To participate in a UNC Lineberger Comprehensive Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all UNC Lineberger Comprehensive Cancer Center trials with current recruitment status updated daily.
Clinical Trials by UNC Lineberger Comprehensive Cancer Center
NCT07226271
Recruiting
Consumer Perceptions of Alcoholic Beverages
Health Behavior
NCT07025785
Recruiting
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
Breast Cancer
NCT06305299 Phase 1
Recruiting
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Ovary Neoplasm
NCT07396766
Recruiting
Dissemination of BREASTChoice AIM1-B
Breast Cancer
NCT06896162
Recruiting
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Solid Tumor Malignancies
NCT06727773 Phase 2
Recruiting
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Breast Cancer
NCT07428330
Recruiting
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV
Cervix Cancer
NCT04223765 Phase 1
Recruiting
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Mantle Cell Lymphoma
NCT05145400 Phase 2
Recruiting
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma
NCT07634653
Recruiting
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
Leukemia
NCT07278557 Phase 2
Recruiting
Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia
Head and Neck Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology